Mid-cap stocks represent companies valued at between $2 billion and $10 billion. If they give investors a reason to be bullish on their growth prospects…
January 09, 2025
January 09, 2025
Three Reasons Why XPOF is Risky and One Stock to Buy Instead
Over the past six months, Xponential Fitness’s shares (currently trading at $14.68) have posted a disappointing 7.4% loss, well below the S&P 500’s 6.1% gain….
FOSTER CITY, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio…
January 08, 2025
Scholar Rock Highlights 2025 Strategic Priorities
CAMBRIDGE, Mass., January 08, 2025–Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and…
January 08, 2025
Allurion Announces Positive Topline Results From AUDACITY Trial
NATICK, Mass., January 08, 2025–Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced topline results from the AUDACITY Food & Drug…
January 08, 2025
Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025
NORWOOD, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced data from its first-in-human dose…
January 08, 2025
Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the…
January 08, 2025
Medifast Launches OPTAVIA ASCEND for Weight Loss Management
MED’s new OPTAVIA ASCEND product line combines high-protein meals, fiber-rich nutrients and personalized coaching.
January 07, 2025
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off
BALTIMORE, January 07, 2025–Medifast (NYSE:MED), the health and wellness company known for its habit based and coach-guided lifestyle solution OPTAVIA, today announced OPTAVIA ASCEND —…
January 07, 2025
Soleno Therapeutics, Inc. (NASDAQ:SLNO): When Will It Breakeven?
We feel now is a pretty good time to analyse Soleno Therapeutics, Inc.’s ( NASDAQ:SLNO ) business as it appears the…
In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $42.53, marking a -0.84% move from the previous day.
Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that…